Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
Life's Door, Jerusalem, Israel.
JCO Oncol Pract. 2021 Jun;17(6):e785-e793. doi: 10.1200/OP.20.00744. Epub 2021 Feb 17.
Hope is a modifiable entity that can be augmented. We evaluated the feasibility, acceptability, and efficacy of a short intervention to increase hopefulness in patients with advanced breast cancer and oncologists.
We enrolled eligible participants to two cohorts: one for patients with metastatic breast cancer and one for medical, radiation, or surgical oncologists. The intervention, a half-day hope enhancement workshop, included groups of 10-15 participants within each cohort. Participants in both cohorts completed preworkshop, postworkshop, and 3-month evaluations, which included the Adult Hope Scale (AHS), Herth Hope Index (HHI), and Patient-Reported Outcomes Measurement Information System-Global Health (PROMIS-GH) measures in patients, and the AHS, HHI, and a burnout self-assessment tool in physicians.
We consented 13 patients and 26 oncologists for participation in the workshop and 76.9% (n = 10) of consented patients and 100% (n = 26) of consented physicians participated. Postworkshop, all participants planned to incorporate what they learned into their daily lives. In patients, AHS scores increased from preworkshop to postworkshop, and the mean change of 5.90 was significant (range 0-15, SD: 4.7, = 3.99, = .0032). HHI scores also increased, although the mean change was not significant. AHS and HHI scores did not significantly change in oncologists from preworkshop to postworkshop. At 3 months, less than half of the participants responded to the evaluation.
We found that conducting a hope-enhancement workshop for patients with metastatic breast cancer and oncologists was feasible, generally acceptable to both populations, and associated with increased hopefulness in patients. Next steps should focus on confirming this effect in a randomized study and maintaining this effect in the postworkshop interval.
希望是一种可以增强的可修正实体。我们评估了一种短期干预措施增加晚期乳腺癌患者和肿瘤医生希望感的可行性、可接受性和疗效。
我们将符合条件的参与者纳入两个队列:一个是转移性乳腺癌患者队列,另一个是医学、放射或外科肿瘤医生队列。干预措施是一个为期半天的希望增强工作坊,每个队列中有 10-15 名参与者组成小组。两个队列的参与者都完成了预工作坊、后工作坊和 3 个月的评估,评估内容包括患者的成人希望量表(AHS)、赫特希望指数(HHI)和患者报告的结局测量信息系统-全球健康(PROMIS-GH)测量,以及医生的 AHS、HHI 和倦怠自我评估工具。
我们同意 13 名患者和 26 名肿瘤医生参加工作坊,76.9%(n=10)的同意患者和 100%(n=26)的同意医生参加了工作坊。工作坊后,所有参与者都计划将所学内容融入日常生活。在患者中,AHS 评分从预工作坊到后工作坊都有所提高,5.90 的平均变化显著(范围 0-15,SD:4.7,=3.99,=0.0032)。HHI 评分也有所提高,尽管平均变化不显著。肿瘤医生的 AHS 和 HHI 评分从预工作坊到后工作坊都没有显著变化。3 个月时,不到一半的参与者对评估做出了回应。
我们发现,为转移性乳腺癌患者和肿瘤医生举办希望增强工作坊是可行的,两种人群都普遍接受,并且与患者希望感的增强有关。下一步应专注于在随机研究中确认这一效果,并在工作坊后保持这一效果。